| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Option exercise(M) | 75K | $7.80 | $585K | 1.0M |
| Sep 1, 2026 | Sell(S) | 7K | $90.79 | $600K | 994K |
| Sep 1, 2026 | Sell(S) | 64K | $91.90 | $5.8M | 930K |
| Sep 1, 2026 | Sell(S) | 5K | $92.44 | $444K | 926K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Sep 1, 2026 | Option exercise(M) | 75K | — | $0 | 1.6M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000907654-26-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Oruka Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.